Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults¹
-
Estrella Immunopharma Announces First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial and Reports Durable Response Rate in Advanced B-Cell Non-Hodgkin’s Lymphoma
-
Infinity Natural Resources Announces Second Quarter 2026 Results Earnings Release and Conference Call Dates
-
DigitalOcean Reduces Leverage with No Effective Dilution and Minimal Cash Usage, Creating Additional Capacity to Fuel Growth
-
A New Movement to Transform America's Public Defense System Takes Center Stage in San Francisco
-
Tricentis Leads for Worldwide Automated Software Quality (ASQ) 2025 Market Share
-
Apex Infusion Partners with SkyKnight Capital
-
Amaero Shares Investor Briefing Recording
-
FangDD Received Nasdaq Notification Regarding Minimum Bid Price Requirement
-
GSJJ Expands Custom Medal Solutions as Demand Grows for Personalized Silver Medals and Recognition Gifts
-
NIP Group Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
-
Liberty Global Reports Q2 2026 Results
-
First Hawaiian, Inc. Reports Second Quarter 2026 Financial Results and Declares Dividend
-
OptimumBank Holdings, Inc. Financial Performance for the Second Quarter of 2026
-
Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026
-
Teamshares to Release Second Quarter 2026 Earnings on August 14, 2026
-
Exyn Defense Expands into Multi-Billion-Dollar Defense Sustainment Market, Bringing Field-Proven AI Autonomy to U.S. Air Force Aircraft Readiness
-
Signorelli Unveils 55-Acre Commerce District at Valley Ranch
-
Gentex Reports Second Quarter 2026 Financial Results
-
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Co
-
Amwell® to report second quarter 2026 operating results
-
Mission Critical Group and CORE Transformers Enter into Merger Agreement
-
United Nations Environment Programme Recognizes Lead Service Line Replacement Cost Calculator
-
Lamb Weston Holdings Announces Quarterly Dividend
-
SEA Index® extends CO₂ certification to the whole recreational yachting sector
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
-
UMD Smith School Researchers Warn AI Security Lapses Highlight Urgent Need for Independent Oversight
-
American Rebel Light Beer Expands Across Pennsylvania; CEO of American Rebel Holdings, Inc. (OTCID:AREB) Andy Ross Performs at Historic York State Fair Continuing Patriotic Summer Brand Activation Str
-
HPE Names David Goulden to Board of Directors
-
American Resources Corporation Declares Special Cash Dividend to Shareholders Following Strategic Transformation
-
BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe
-
TelyRx to Host Second Quarter 2026 Financial Results Conference Call on Monday, August 10, 2026 at 8:30 am ET
-
Tax Goddess Disrupts CPA Model with Flat-Rate Strategy Tiers to Protect HNW Wealth
-
CN Declares Third-Quarter 2026 Dividend
-
Global AI Leader and Enterprise Transformation Visionary Zeya Ottomone Appointed Chief Executive Officer of Integrow
-
MoonExe Announces Itself to the World The First Global ExFi Solutions Provider for Cross-border Payments
-
HCA Healthcare Reports Second Quarter 2026 Results
-
World Acceptance Corporation Reports Fiscal 2027 First Quarter Results
-
NextEra Energy second-quarter 2026 financial results available on company's website
-
Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
-
Lufax Announces Board and Management Changes
-
AGF Investments Announces July 2026 Cash Distributions for AGF Enhanced U.S. Equity Income Fund, AGF Enhanced U.S. Income Plus Fund, AGF Total Return Bond Fund and AGF Systematic Global Infrastructure
-
Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union
-
Postal Realty Trust, Inc. to Report Second Quarter 2026 Financial Results on August 4, 2026
-
CN Delivers on Commitments with Strong Second Quarter Results and Raises 2026 Guidance
-
Dyadic Announces Continued Listing on the Nasdaq Capital Market
-
ChoiceOne Reports Second Quarter 2026 Results
-
New 12-Week Coaching Program by Torchlight Vitality Offers Women a Practical, Step-by-Step Path to Managing Fibromyalgia Symptoms
-
GreenHat Announces Successful Delegation at Web Summit Vancouver 2026
